Similarly, CYFIP1 exhibited negative correlations with these immune signatures and showed a poor prognosis in tumors such as BRCA, LUSC, mesothelioma (MESO), sarcoma (SARC), and THCA. The gene discussed is CYFIP1; the disease is sarcoma.